Vycor Medical (VYCO) Net Income Growth (5y) (2015 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | Vycor Medical | - | - | 375,153.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 14.88% |
| Dec 31, 2025 | 43.19% |
| Sep 30, 2025 | -14.90% |
| Jun 30, 2025 | 42.77% |
| Mar 31, 2025 | 65.30% |
| Dec 31, 2024 | 71.61% |
| Sep 30, 2024 | 71.83% |
| Jun 30, 2024 | 73.47% |
| Mar 31, 2024 | -14.88% |
| Dec 31, 2023 | 65.08% |
| Sep 30, 2023 | -14.90% |
| Jun 30, 2023 | -14.94% |
| Mar 31, 2023 | -14.89% |
| Dec 31, 2022 | 71.54% |
| Sep 30, 2022 | 64.27% |
| Jun 30, 2022 | 67.62% |
| Mar 31, 2022 | 70.04% |
| Dec 31, 2021 | 71.11% |
| Sep 30, 2021 | 58.75% |
| Jun 30, 2021 | 49.21% |
| Mar 31, 2021 | 52.94% |
| Dec 31, 2020 | 58.38% |
| Sep 30, 2020 | 15.38% |
| Jun 30, 2020 | 41.12% |
| Mar 31, 2020 | 57.76% |
| Sep 30, 2019 | 54.40% |
| Jun 30, 2019 | 50.68% |
| Mar 31, 2019 | 17.39% |
| Dec 31, 2018 | 0.91% |
| Sep 30, 2018 | 18.06% |
| Jun 30, 2018 | 21.53% |
| Mar 31, 2018 | 20.04% |
| Dec 31, 2017 | 7.69% |
| Sep 30, 2017 | 11.41% |
| Jun 30, 2017 | 14.68% |
| Mar 31, 2017 | 16.78% |
| Dec 31, 2016 | 11.12% |
| Sep 30, 2016 | 21.99% |
| Jun 30, 2016 | 30.14% |
| Mar 31, 2016 | 10.83% |
| Dec 31, 2015 | 13.64% |
| Sep 30, 2015 | -7.26% |
| Jun 30, 2015 | 0.00% |